본문 바로가기
KERD
논문KCI 등재

Screening of Anti-Adhesion Agents for Pathogenic Escherichia coli O157:H7 by Targeting the GrlA Activator

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류생물학

초록

Enterohemorrhagic Escherichia coli (EHEC) is a foodborne pathogen that produces attaching and effacing lesions on the large intestine and causes hemorrhagic colitis. It is primarily transmitted through the consumption of contaminated meat or fresh produce. Similar to other bacterial pathogens, antibiotic resistance is of concern for EHEC. Furthermore, since the production of Shiga toxin by this pathogen is enhanced after antibiotic treatment, alternative agents that control EHEC are necessary. This study aimed to discover alternative treatments that target virulence factors and reduce EHEC toxicity. The locus of enterocyte effacement (LEE) is essential for EHEC attachment to host cells and virulence, and most of the LEE genes are positively regulated by the transcriptional regulator, Ler. GrlA protein, a transcriptional activator of ler, is thus a potential target for virulence inhibitors of EHEC. To identify the GrlA inhibitors, an in vivo high-throughput screening (HTS) system consisting of a GrlA-expressing plasmid and a reporter plasmid was constructed. Since the reporter luminescence gene was fused to the ler promoter, the bioluminescence would decrease if inhibitors affected the GrlA. By screening 8,201 compounds from the Korea Chemical Bank, we identified a novel GrlA inhibitor named Grlactin [3-[(2,4-dichlorophenoxy)methyl]-4-(3-methylbut2-en-1-yl)-4,5-dihydro-1,2,4-oxadiazol-5-one], which suppresses the expression of LEE genes. Grlactin significantly diminished the adhesion of EHEC strain EDL933 to human epithelial cells without inhibiting bacterial growth. These findings suggest that the developed screening system was effective at identifying GrlA inhibitors, and Grlactin has potential for use as a novel antiadhesion agent for EHEC while reducing the incidence of resistance.

Abstract

Enterohemorrhagic Escherichia coli (EHEC) is a foodborne pathogen that produces attaching and effacing lesions on the large intestine and causes hemorrhagic colitis. It is primarily transmitted through the consumption of contaminated meat or fresh produce. Similar to other bacterial pathogens, antibiotic resistance is of concern for EHEC. Furthermore, since the production of Shiga toxin by this pathogen is enhanced after antibiotic treatment, alternative agents that control EHEC are necessary. This study aimed to discover alternative treatments that target virulence factors and reduce EHEC toxicity. The locus of enterocyte effacement (LEE) is essential for EHEC attachment to host cells and virulence, and most of the LEE genes are positively regulated by the transcriptional regulator, Ler. GrlA protein, a transcriptional activator of ler, is thus a potential target for virulence inhibitors of EHEC. To identify the GrlA inhibitors, an in vivo high-throughput screening (HTS) system consisting of a GrlA-expressing plasmid and a reporter plasmid was constructed. Since the reporter luminescence gene was fused to the ler promoter, the bioluminescence would decrease if inhibitors affected the GrlA. By screening 8,201 compounds from the Korea Chemical Bank, we identified a novel GrlA inhibitor named Grlactin [3-[(2,4-dichlorophenoxy)methyl]-4-(3-methylbut2-en-1-yl)-4,5-dihydro-1,2,4-oxadiazol-5-one], which suppresses the expression of LEE genes. Grlactin significantly diminished the adhesion of EHEC strain EDL933 to human epithelial cells without inhibiting bacterial growth. These findings suggest that the developed screening system was effective at identifying GrlA inhibitors, and Grlactin has potential for use as a novel antiadhesion agent for EHEC while reducing the incidence of resistance.

참고문헌 (42)

  1. Clatworthy AE, "Targeting virulence: a new paradigm for antimicrobial therapy", Nat. Chem. Biol, 3, pp.541~548 (2007)
  2. Roope LSJ, "The challenge of antimicrobial resistance: What economics can contribute", Science, 364, pp.eaau4679~ (2019)
  3. "Antibiotic resistant threats in the United States" (2019)[URL]
  4. "Tackling drug-resistant infections globally: final report and recommendations" (2016)[URL]
  5. Tarr PI, "Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome", Lancet, 365, pp.1073~1086 (2005)
  6. Lee MS, "Recent advances in understanding the pathogenesis of Shiga toxin-producing Shigella and Escherichia coli", Front. Cell. Infect. Microbiol, 10, pp.620703~ (2020)
  7. 정유진, "Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome", Journal of Microbiology and Biotechnology, 28(9), pp.1413~1425 (2018), 한국미생물·생명공학회
  8. Lee KS, "Exosomes released from Shiga toxin 2a-treated human macrophages modulate inflammatory responses and induce cell death in toxin receptor expressing human cells", Cell Microbiol, 22, pp.e13249~ (2020)
  9. Kim JS, "Recent updates on outbreaks of Shiga toxin-producing Escherichia coli and its potential reservoirs", Front. Cell. Infect. Microbiol, 10, pp.273~ (2020)
  10. Freedman SB, "Shiga toxin–producing Escherichia coli infection, antibiotics, and risk of developing hemolytic uremic syndrome: a meta-analysis", Clin. Infect. Dis, 62, pp.1251~1258 (2016)
  11. Moon H, "Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines", Infect. Immun, 41, pp.1340~1351 (1983)
  12. Croxen MA, "Molecular mechanisms of Escherichia coli pathogenicity", Nat. Rev. Microbiol, 8, pp.26~38 (2010)
  13. Jerse AE, "A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells", Proc. Natl. Acad. Sci. USA, 87, pp.7839~7843 (1990)
  14. Knutton S, "Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli", Infect. Immun, 57, pp.1290~1298 (1989)
  15. Elliott SJ, "The complete sequence of the locus of enterocyte effacement (LEE) from enteropathogenic Escherichia coli E2348", 69, 1998, pp.28, 1~4
  16. Mellies JL, "The Per regulon of enteropathogenic Escherichia coli:identification of a regulatory cascade and a novel transcriptional activator, the locus of enterocyte effacement (LEE)‐encoded regulator (Ler)", Mol. Microbiol, 33, pp.296~306 (1999)
  17. Jarvis KG, "Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation", Proc. Natl. Acad. Sci. USA, 92, pp.7996~8000 (1995)
  18. Naylor SW, "Escherichia coli O157: H7 forms attaching and effacing lesions at the terminal rectum of cattle and colonization requires the LEE4 operon", Microbiology, 151, pp.2773~2781 (2005)
  19. Franzin FM, "Locus of enterocyte effacement: A pathogenicity island involved in the virulence of enteropathogenic and enterohemorragic Escherichia coli subjected to a complex network of gene regulation", BioMed Res. Int, 2015, pp.534738~ (2015)
  20. Deng W, "Dissecting virulence: Systematic and functional analyses of a pathogenicity island", Proc. Natl. Acad. Sci. USA, 101, pp.3597~3602 (2004)
  21. Barba J, "A positive regulatory loop controls expression of the locus of enterocyte effacement-encoded regulators Ler and GrlA", J. Bacteriol, 187, pp.7918~7930 (2005)
  22. Beltrametti F, "Transcriptional regulation of the esp genes of enterohemorrhagic Escherichia coli", J. Bacteriol, 181, pp.3409~3418 (1999)
  23. Alsharif G, "Host attachment and fluid shear are integrated into a mechanical signal regulating virulence in Escherichia coli O157:H7", Proc. Natl. Acad. Sci. USA, 112, pp.5503~5508 (2015)
  24. Yang B, "Enterohemorrhagic Escherichia coli senses low biotin status in the large intestine for colonization and infection", Nat. Commun, 6, pp.6592~ (2015)
  25. Sirisaengtaksin N, "The E. coli transcription factor GrlA is regulated by subcellular compartmentalization and activated in response to mechanical stimuli", Proc. Natl. Acad. Sci. USA, 117, pp.9519~9528 (2020)
  26. Kim SM, "Development of an HTS system to identify natural chemicals that specifically inhibit Escherichia coli O157:H7 adhesion to host cells", Food Control, 73, pp.185~192 (2017)
  27. 김현정, "다이오스민(diosmin)에 의한 병원성 대장균 세포부착 및 생물막 형성 억제", 한국식품과학회지, 50(4), pp.414~419 (2018), 한국식품과학회[DOI]
  28. Hou M, "Genetic editing of the virulence gene of Escherichia coli using the CRISPR system", PeerJ, 8, pp.e8881~ (2020)
  29. Kim BS, "QStatin, a selective inhibitor of quorum sensing in Vibrio species", mBio, 9, pp.e02262-02217~ (2018)
  30. Dibb-Fuller M, "An in-vitro model for studying the interaction of Escherichia coli O157: H7 and other enteropathogens with bovine primary cell cultures", J. Med. Microbiol, 50, pp.759~769 (2001)
  31. Dahan S, "Transcriptome of enterohemorrhagic Escherichia coli O157adhering to eukaryotic plasma membranes", Infect. Immun, 72, pp.5452~5459 (2004)
  32. Falkow S, "Molecular Koch's postulates applied to microbial pathogenicity", Rev. Infect.Dis, Suppl 2, pp.S274~S276 (1988)
  33. Falkow S, "Molecular Koch's postulates applied to bacterial pathogenicity—a personal recollection 15 years later", Nat. Rev. Microbiol, 2, pp.67~72 (2004)
  34. Lee Z-W, "Small-molecule inhibitor of HlyU attenuates virulence of Vibrio species", Sci. Rep, 9, pp.4346~ (2019)
  35. Padavannil A, "Structure of GrlR–GrlA complex that prevents GrlA activation of virulence genes", Nat. Commun, 4, pp.2546~ (2013)
  36. Sperandio V, "Activation of enteropathogenic Escherichia coli (EPEC) LEE2 and LEE3 operons by Ler", Mol. Microbiol, 38, pp.781~793 (2000)
  37. Bustamante VcH, "Transcriptional regulation of type III secretion genes in enteropathogenic Escherichia coli: Ler antagonizes H‐NS‐dependent repression", Mol. Microbiol, 39, pp.664~678 (2001)
  38. Russell RM, "QseA and GrlR", GrlA regulation of the locus of enterocyte effacement genes in enterohemorrhagic Escherichia coli, 2007, pp.189, 5387~5392
  39. Furniss RCD, "Regulation of the locus of enterocyte effacement in attaching and effacing pathogens", J. Bacteriol, 200, pp.e00336-00317~ (2018)
  40. Lim JG, "Characterization of the Vibrio vulnificus 1-Cys peroxiredoxin Prx3 and regulation of its expression by the Fe-S cluster regulator IscR in response to oxidative stress and iron starvation", J. Biol. Chem, 289, pp.36263~36274 (2014)
  41. Lenz DH, "The small RNA chaperone Hfq and multiple small RNAs control quorum sensing in Vibrio harveyi and Vibrio cholerae", Cell, 118, pp.69~82 (2004)
  42. Jiang Y, "Multigene editing in the Escherichia coli genome via the CRISPR-Cas9system", Appl. Environ. Microbiol, 81, pp.2506~2514 (2015)

관련 논문AI추천

Discovery of a Small-Molecule Inhibitor Targeting the Biofilm Regulator BrpT in Vibrio vulnificus최상호, Bang Ye-Ji, Choi Wonwoo, Lee Hojun, Wang Qiyao한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제11호Characterization of Diarrheagenic Escherichia coli Isolated from Fresh Beef, Pork, and Chicken Meat in Korean Markets구민선, 장혜진, 조용선한국미생물·생명공학회 · 한국미생물·생명공학회지2020 · 제48권 제2호Two Enteropathogenic Escherichia coli Strains Representing Novel Serotypes and Investigation of Their Roles in AdhesionGuo Xi, Hu Bin, Jiao HongBo, Sun Na, Wang Jing, Wei Yi, Ying Yang, Zhang XinFeng, Zhang YuanQing한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2021 · 제31권 제9호Variations in the Antivirulence Effects of Fatty Acids and Virstatin against Vibrio cholerae StrainsBae Jonghyun, Choi Hunseok, Joo Jayun, Kim Dong Wook, Kim Eun Jin, Lee Donghyun, Son Seonghyeon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2024 · 제34권 제9호Advanced Three-Dimensional Cell Culture Models for Investigating Enterohaemorrhagic Escherichia coli Pathogenesis and Shiga Toxin-Mediated InjuryJeong Yujin, Kim Mirim, Lee Moo-Seung, Park So-Hyeon한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 Development of a One-Step PCR Assay with Nine Primer Pairs for the Detection of Five Diarrheagenic Escherichia coli Types오경환, Mi-Sun Park, SEUNG-HAK CHO, Soo-Bok Kim한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2014 · 제24권 제6호

이 간행물의 다른 논문 (14건)